Please login to the form below

Not currently logged in
Email:
Password:

M3 expands with acquisition of Vidal Group

Grows global operations to cover Europe and Latin America

M3M3, the healthcare services provider, has expanded its global operations with the acquisition of healthcare informatics firm Vidal Group.

In a move to complement its existing business activities across the UK, US and Asia, M3 is now set to support the growth of Vidal's services focusing on key markets in Europe and Latin America.

Vidal Group currently specialises in providing reference drug information for healthcare professionals, with online databases tailored to cover all the latest treatment information and medical advances.

Now part of the M3 network - which includes M3.com, MDLinx, Medigate, medlive.cn, M3Medical and Doctors.net.uk - the group will also offer market research, digital communications and clinical trials and recruitment services.

Aki Tomaru, board director and chief executive of M3 USA, said: “The addition of the Vidal Group to M3 marks a very significant and important step for M3 in its mission to deliver trusted and high quality medical information and services in key markets across the world to drive forward innovation, improved efficiency and better outcomes in healthcare.”

Article by
Rebecca Clifford

21st December 2016

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Aptus Health

Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...

Latest intelligence

Is China ready for a pharmaceutical gold rush?
Some describe doing business in China as akin to the 1990s internet boom – so how stable is its future?...
AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...

Infographics